We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
-2.96%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$21.8B
AUM Growth
-$767M
Cap. Flow
+$148M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.44%
Holding
1,924
New
62
Increased
766
Reduced
660
Closed
101

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$77.8M
2
TREX icon
Trex
TREX
+$39.7M
3
DOCU
DocuSign
DOCU
+$17.2M
4
AKAM icon
Akamai
AKAM
+$16.6M
5
GLD icon
SPDR Gold Trust
GLD
+$13.1M

Sector Composition

Rank Sector Weight
1 Technology 23.15%
2 Healthcare 19.33%
3 Financials 11.9%
4 Industrials 11.25%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHX icon
901
Schwab US Large- Cap ETF
SCHX
$75B
$755K ﹤0.01%
53,508
-2,997
-5% -$47K
SMPL icon
902
Simply Good Foods
SMPL
$989M
$755K ﹤0.01%
23,607
-6,754
-22% -$222K
NFE icon
903
New Fortress Energy
NFE
$93M
$753K ﹤0.01%
17,230
-741
-4% -$37.2K
LUV icon
904
Southwest Airlines
LUV
$22B
$752K ﹤0.01%
24,370
-6,098
-20% -$228K
STOR
905
DELISTED
STORE Capital Corporation
STOR
$752K ﹤0.01%
24,007
-4,164
-15% -$118K
GTLS
906
DELISTED
Chart Industries
GTLS
$748K ﹤0.01%
4,056
+138
+4% +$25.6K
MXCT icon
907
MaxCyte
MXCT
$149M
$748K ﹤0.01%
115,005
-20,685
-15% -$115K
VT icon
908
Vanguard Total World Stock ETF
VT
$81.9B
$748K ﹤0.01%
9,479
+8,542
+912% +$751K
IHE icon
909
iShares US Pharmaceuticals ETF
IHE
$1.65B
$745K ﹤0.01%
13,176
+387
+3% +$23.8K
OTIS icon
910
Otis Worldwide
OTIS
$27.8B
$742K ﹤0.01%
11,624
+1,521
+15% +$111K
IBDO
911
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$742K ﹤0.01%
29,755
LYB icon
912
LyondellBasell Industries
LYB
$20.2B
$737K ﹤0.01%
9,785
-1,052
-10% -$88.9K
PEG icon
913
Public Service Enterprise Group
PEG
$37.8B
$736K ﹤0.01%
13,094
+1,175
+10% +$75.7K
GGT
914
Gabelli Multimedia Trust
GGT
$175M
$735K ﹤0.01%
119,363
-1,948
-2% -$13.9K
GNR icon
915
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.9B
$735K ﹤0.01%
14,861
+6,884
+86% +$363K
APPN icon
916
Appian
APPN
$2.65B
$734K ﹤0.01%
17,983
-1,740
-9% -$84.4K
EVRG icon
917
Evergy
EVRG
$19.3B
$734K ﹤0.01%
12,360
-766
-6% -$51.5K
EXPD icon
918
Expeditors International
EXPD
$24.3B
$733K ﹤0.01%
8,297
-933
-10% -$93.4K
KSS icon
919
Kohl's
KSS
$2.22B
$733K ﹤0.01%
29,156
-981
-3% -$28.6K
CF icon
920
CF Industries
CF
$17.7B
$731K ﹤0.01%
7,598
-68,874
-90% -$6.72M
AMJ
921
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$730K ﹤0.01%
36,378
-1,180
-3% -$24.7K
CAG icon
922
Conagra Brands
CAG
$7.39B
$728K ﹤0.01%
22,316
-2,389
-10% -$82K
BOOT icon
923
Boot Barn
BOOT
$4.92B
$724K ﹤0.01%
12,378
-163
-1% -$10.9K
MSCI icon
924
MSCI
MSCI
$41.8B
$721K ﹤0.01%
1,710
-14
-0.8% -$6.41K
GKOS icon
925
Glaukos
GKOS
$11.2B
$720K ﹤0.01%
13,522
-10,115
-43% -$522K

Similar funds

William Blair & Company's Q3 2022 Portfolio in Review

As of Q3 2022, William Blair & Company held 1,924 positions worth $21.8B, down 3.4% from $22.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

William Blair & Company's Q3 2022 filing shows 62 new, 766 increased, 660 reduced and 101 closed positions. Its largest new stake was GSK: 37,792 shares worth $1.11M. The largest sale was Atlassian, an estimated $77.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q3 2022 buy was GSK: 37,792 shares worth $1.11M.
  • William Blair & Company added most to Watsco Inc in Q3 2022, an estimated $31.3M increase.
  • William Blair & Company's biggest Q3 2022 reduction was Trex, cutting an estimated $39.7M.
  • William Blair & Company fully exited Atlassian in Q3 2022, selling an estimated $77.8M.
  • William Blair & Company's ten largest holdings make up 23% of its $21.8B portfolio in Q3 2022.
  • William Blair & Company opened 62 new positions and closed 101 in Q3 2022.
  • William Blair & Company's portfolio value fell 3.4% quarter-over-quarter to $21.8B.

Based on William Blair & Company's 13F filing for Q3 2022, filed 9 Nov 2022.